In studies of malignant solid tumors, such as CRC, breast cancer, and prostate cancer, S100A8 and S100A9 levels have been found to be elevated in tumor tissues compared with normal and benign tissues, and their increased expression has been associated with tumor aggressiveness and metastasis [78–80]. The gene discussed is S100A9; the disease is neoplasm.